183 related articles for article (PubMed ID: 16509455)
1. Renal expression of ICAM-1 and VCAM-1 in ANCA-associated glomerulonephritis--are there differences among serologic subgroups?
Arrizabalaga P; Solé M; Iglesias C; Escaramís G; Ascaso C
Clin Nephrol; 2006 Feb; 65(2):79-86. PubMed ID: 16509455
[TBL] [Abstract][Full Text] [Related]
2. Renal expression of adhesion molecules in anca-associated disease.
Arrizabalaga P; Solé M; Abellana R; Ascaso C
J Clin Immunol; 2008 Sep; 28(5):411-9. PubMed ID: 18574676
[TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
4. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
5. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.
Hauer HA; Bajema IM; van Houwelingen HC; Ferrario F; Noël LH; Waldherr R; Jayne DR; Rasmussen N; Bruijn JA; Hagen EC;
Kidney Int; 2002 Jan; 61(1):80-9. PubMed ID: 11786087
[TBL] [Abstract][Full Text] [Related]
6. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
7. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
Fienberg R; Mark EJ; Goodman M; McCluskey RT; Niles JL
Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764
[TBL] [Abstract][Full Text] [Related]
8. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
10. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis.
Hakroush S; Tampe D; Ströbel P; Korsten P; Tampe B
Front Immunol; 2021; 12():737708. PubMed ID: 34759920
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis.
Damoiseaux JG; Slot MC; Vaessen M; Stegeman CA; Van Paassen P; Tervaert JW
J Clin Immunol; 2005 May; 25(3):202-8. PubMed ID: 15981084
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
14. Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA).
Wang G; Csernok E; de Groot K; Gross WL
J Immunol Methods; 1997 Oct; 208(2):203-11. PubMed ID: 9433475
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Harper L; Cockwell P; Adu D; Savage CO
Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity in kidney diseases.
Kettritz R
Scand J Clin Lab Invest Suppl; 2008; 241():99-103. PubMed ID: 18569975
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to proteinase-3 mediate expression of intercellular adhesion molecule-1 (ICAM-1, CD 54).
De Bandt M; Meyer O; Hakim J; Pasquier C
Br J Rheumatol; 1997 Aug; 36(8):839-46. PubMed ID: 9291851
[TBL] [Abstract][Full Text] [Related]
19. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies.
Franssen C; Gans R; Kallenberg C; Hageluken C; Hoorntje S
J Intern Med; 1998 Sep; 244(3):209-16. PubMed ID: 9747743
[TBL] [Abstract][Full Text] [Related]
20. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]